Biomerica (BMRA) Gross Profit (QoQ) (2011 - 2026)
Biomerica (BMRA) Gross Profit (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn |
| 10 | Biomerica | 4.88 Mn | 3.54 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -186.27% |
| Nov 30, 2025 | -87.97% |
| Aug 31, 2025 | 273.77% |
| May 31, 2025 | -1,384.21% |
| Feb 28, 2025 | -95.65% |
| Nov 30, 2024 | 51.21% |
| Aug 31, 2024 | 1,345.00% |
| May 31, 2024 | 113.42% |
| Feb 29, 2024 | -145.85% |
| Nov 30, 2023 | -21.12% |
| Aug 31, 2023 | 1,320.69% |
| May 31, 2023 | -75.83% |
| Feb 28, 2023 | -65.91% |
| Nov 30, 2022 | 740.00% |
| Aug 31, 2022 | -108.86% |
| May 31, 2022 | -62.89% |
| Feb 28, 2022 | 116.81% |
| Nov 30, 2021 | 967.44% |
| Aug 31, 2021 | -789.26% |
| May 31, 2021 | 117.58% |